затлъстяване, лекувани с метформин или сулфанилурея, се наблюдава подобрение на HbA1c и телесното тегло.
In the trial in type 2 diabetic patients (RIO-Diabetes) who were overweight or obese treated with metformin or sulfonylurea improvements in HbA1c and body weight were observed.